Navigation Links
Catalent Launches OptiForm® Solution Suite for Accelerated Drug Development and Showcases Advanced Development and Manufacturing Technologies at CPhI Worldwide
Date:10/1/2015

Catalent Pharma Solutions (Stand 3G10), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced a full agenda for the upcoming CPhI Worldwide Conference and Exhibition to be held at the Feria de Madrid, Spain, from October 12th to 15th.

At the conference, Catalent is launching its new OptiForm® Solution Suite platform, designed to match the best, most innovative, drug delivery technologies to each developmental molecule with the goal of providing optimal candidate formulations for animal PK studies in twelve weeks. Combining four technologies, including advanced parallel screening, OptiForm Solution Suite aims to enhance drug bioavailability and to accelerate more molecules to the clinic and beyond.

Catalent will also be showcasing a number of its advanced development and manufacturing technologies during the show, highlighting its tech transfer capabilities and flexible manufacturing solutions, including custom manufacturing suites, and the ability to handle cytotoxic and highly potent APIs. The company will detail how it has successfully combined these facilities and expertise to launch 175 new products to the market in 2014.

At the Pre-Connect Conference, on Monday October 12th, a number of Catalent experts will be chairing sessions and presenting including:

  •     Track One Module A: Drug Delivery & Design

9.30 - 9.45 a.m. “Drug Design: Incorporating Patient and Market Needs from the Start of the Development Process,” Sharon Johnson, Senior Vice President, Product Development and Regulatory Affairs
9.45 - 10.05 a.m. “A Structured Approach to Accelerating Drug Development enabled by innovative delivery technologies,” P.Y. Chen, Director, Early Development
10.25 - 10.50 a.m. “How Preformulation and Formulation Development can Optimise API Properties for Better Drug Design,” Dr. Elanor Pinto, Technical Project Manager, co-presenting with Dr. Ali Rajabi-Siahboomi, VP & Chief Scientific Officer, Colorcon Inc.

  •     Track One Module B: Biologics, Biosimilars & Biobetters

12.10 - 12.30 p.m. “Case Study: Bringing Biosimilars to Market Faster with Innovative Technologies, Development Models and Successful Collaborations,” Dr. Christelle Dagoneau, Business Development Director, Biologics, co-presenting with Roman Ivanov, Vice President Research & Development, Biocad

  •     Senior Leadership Theatre

5.05 - 6.05 p.m. “From Pipeline to Patient: Leadership Perspectives on Market Development and Commercialisation,” Sharon Johnson, Senior Vice President, Quality, Product Development and Regulatory Affairs

During the exhibition, two Catalent executives will be speaking as part of the Exhibitor Showcase schedule:

  •     13th October, 2.30 p.m.: Michael Valazza, Vice President, Global Business Development, Advanced Delivery Technologies. His presentation will cover “Flexible Manufacturing Solutions: From Special Handling to Custom Suites;”
  •     14th October, 11.30 a.m.: Bill Hartzel, Director, Strategic Execution, Advanced Delivery Technologies will discuss "Mitigating the Risk of Aseptic Filling with an Automated Advanced Aseptic Process for Glass-Free Injectable Vials."

Catalent is also participating in two Pharma Insight Briefings during the show on Tuesday, October 13th:

  •     12.00 p.m.: Dan Peizer, Director of Global Sales and Marketing, Animal Health, will present “Latest Trends in Animal Health, Using Advanced Human Technologies to Deliver Breakthrough Improvements in Product Delivery;”
  •     1.00 p.m.: Claudia Valla, Product Development Adviser, will discuss “Softgel as an Innovative, Flexible Delivery Form with More Consumer Preferred Benefits.”

Catalent has also been shortlisted in the CPhI Awards for the “Process and Formulation Development” category for its OptiShell™ gelatin-free softgel capsules, as well as in the “Packaging” category for its innovative, glass-free ADVASEPT® Lock advanced aseptic technology.

For further information or to arrange a meeting with a member of the executive team at the show, please contact Richard Kerns at richard@nepr.eu

About Catalent
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,700 people, including over 1,000 scientists, at 31 facilities across 5 continents, and in fiscal 2015 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Read the full story at http://www.prweb.com/releases/2015/10/prweb12996829.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. Catalent’s Clinical Trial Supply Facility in Shanghai, China Opens for Business
2. Pure MHC and Catalent Sign RL21 Anti-Cancer Development Deal
3. Catalent Expert to Present on Enhancing Bioavailability of Poorly Absorbed Drugs at Japan Society of Drug Delivery Systems
4. Catalent and Minomic Collaborate to Bring New Prostate Cancer Treatment to Market
5. Critical Path Sourcing Strategies for Global Clinical Trials Presented by Catalent Experts at US Clinical Trials Supply Conference
6. Catalent Supports Eli Lilly's Growing Global Clinical Trials Needs with New Investment in Automated Packaging Solutions
7. Catalent Announces Two Senior Appointments to its Biologics Business
8. Bioavailability and Controlled Release Symposium Announced by Catalent Applied Drug Delivery Institute
9. Best Practice and Strategies in Risk Mitigation to be Presented by Catalent Expert at Internal Audit Summit
10. New OptiPact™ Technology Introduced by Catalent
11. Catalent and Cingulate Therapeutics Sign Exclusive Agreement for Development of New ADHD Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2019)... ... 2019 , ... Santa Rosa Consulting, Inc. , a ... industry, has completed the first phase of a comprehensive strategic and technological initiative ... towards a fully integrated health information management system (iHIMS). , The first ...
(Date:10/8/2019)... ... October 08, 2019 , ... Safe Harvest soups in ... King Sooper, Fry’s, Roundy’s, Smiths and Dillons. , Safe Harvest reinvented classic soup ... “Ingredient purity and fresh taste is paramount for us,” says Bryan Boches, co-founder ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... a majority interest in Advanced Fertility Care (AFC), an advanced reproductive services (RE) ... to expand the availability of RE services to expectant families throughout Arizona and ...
(Date:10/8/2019)... Hartford, CT (PRWEB) , ... October 08, 2019 ... ... at JawFixers in West Hartford, CT, help patients with missing teeth restore their ... year, this team of oral surgeons relies on advanced i-CAT® 3D Cone Beam ...
(Date:10/8/2019)... ... October 08, 2019 , ... Over the past three decades, Buffalo ... in the sports restaurant category by providing a higher-quality product and experience than the ... as well as a "RAISE A MUG FOR THE CAUSE" campaign in support of ...
Breaking Medicine News(10 mins):
(Date:10/8/2019)... ... October 08, 2019 , ... Help.org, a trusted online ... Best Rehab Facilities in Boston, Massachusetts for 2019. The informational guide recognizes the top ... , According to recent studies , drug overdose is the leading cause of ...
(Date:10/8/2019)... , ... October 08, 2019 , ... ... in an advanced dental implant seminar to enhance his skill and knowledge of ... The Implant Dentistry Continuum™ is a four-part series of classes that combines in-depth ...
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... Villa Healthcare, ... contest asking why they chose to work at Villa and what their work means ... CEO Mark Berger and CFO Steve Nagel prepared the giant checks. Anticipation was ...
Breaking Medicine Technology: